Dec 9 (Reuters) - CVS Health (CVS) on Tuesday forecast 2026 profit above Wall Street estimates and this year's projected earnings, signalling steady progress in the health conglomerate's turnaround plan.
CVS stock rose 5% in early trading on Tuesday.
The company in October projected double-digit earnings growth for 2026 after raising its 2025 profit forecast for the third time.
"We are closing out 2025 with meaningful momentum across our businesses and we expect another year of strong earnings growth in 2026," said Chief Financial Officer Brian Newman on Tuesday.
The company forecast 2026 adjusted profit to be in the range of $7.00 to $7.20 per share, compared with analysts' average estimate of $7.16, according to data compiled by LSEG.
It, however, expects total revenue of at least $400 billion next year, below analysts' average estimate of $419.26 billion.
CVS also raised its 2025 adjusted profit forecast to $6.60 to $6.70 per share from $6.55 to $6.65 previously.
(Reporting by Sneha S K in Bengaluru; Editing by Shinjini Ganguli)
LATEST POSTS
- 1
The Advancement and Effect of Dental Embed Innovation on Oral Wellbeing - 2Audits of the Top Science fiction Movies This Year
- 3Pick Your Favored method of transportation
- 4People can't get enough of this couple's Hallmark movie reviews. They don't know the painful backstory.
- 56 Famous Urban communities for Shopping on the planet
- Partake in the Outside: Senior-Accommodating Exercises for 2024
- Pick Your Favored kind of soup
- World leaders, rights groups react to COP30 climate deal
- I took my shoes off and went for a barefoot hike. I couldn’t believe what happened next
- 'Wicked: For Good' was filmed at this surreal National Park in Egypt
- A few Exemplary Chinese Dishes, Which Are Famous Around the world
- Eat Well, Live Well: An Extensive Manual for Smart dieting and Sustenance
- Striking American and European television Projects: A Survey
- Flourishing in Retirement: Individual Accounts of Post-Profession Satisfaction
